Sabby Management, LLC Bristol Myers Squibb CO Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $1.18 Million - $1.47 Million	-23,312 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $54.4 Million - $62.7 Million	-908,495 Reduced 97.5%	23,312 $1.47 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $3.07 Million - $3.34 Million	-51,148 Reduced 5.2%	931,807 $57.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $54.3 Million - $62.7 Million	982,955	982,955 $62.7 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.